LUCD · Lucid Diagnostics Inc
United States · RS rating 5 · As of 2026-10-14
| Price | 0.54 USD |
|---|---|
| 1-day change | -10.4% |
| RS rating (overall / 1M / 3M / 12M) | 5 / 6 / 6 / 13 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 28 / 15 / 31 |
| Industry group (rank) | Medical-Products (98) |
| EPS growth Q/Q | +0.0% |
| Sales growth Q/Q | +24.2% |
| Distance from 52-week high | +63.0% |
| Market cap (USD) | $185.7M |